title: Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
authors: Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee, Scotland, UK.
authors: Meghan R
authors: MR
authors: Perry
authors: Susan
authors: S
authors: Wyllie
authors: Vijay Kumar
authors: VK
authors: Prajapati
authors: Joerg
authors: J
authors: Feldmann
authors: Shyam
authors: S
authors: Sundar
authors: Marleen
authors: M
authors: Boelaert
authors: Alan H
authors: AH
authors: Fairlamb
mesh_terms: D000965:Antimony / Q000008:administration & dosage* / Q000494:pharmacology; D000981:Antiprotozoal Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001151:Arsenic / Q000378:metabolism*; D004351:Drug Resistance; D006801:Humans; D007194:India / Q000453:epidemiology; D007891:Leishmania; D007893:Leishmania donovani / Q000187:drug effects; D018314:Leishmania infantum / Q000187:drug effects; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000453:epidemiology*; D011042:Poisons / Q000378:metabolism; D017211:Treatment Failure
chemical_list: D000981:Antiprotozoal Agents; D011042:Poisons; D000965:Antimony; D001151:Arsenic